Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $50 million SEC-registered common stock and pre-funded warrants offering by Tenaya Therapeutics, Inc. Tenaya’s common stock is listed on the Nasdaq Global Select Market under the symbol “TNYA.”
Based in South San Francisco, California, Tenaya is a clinical-stage biotechnology company focused on discovering, developing and delivering potentially curative therapies to address the underlying drivers of heart disease.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Elsie Cheang and Jacquiley Wong. Partner David R. Bauer and associate Alexis N. Wallace provided intellectual property advice. The tax team included partner Mario J. Verdolini and associate Michael Mirabella. Members of the Davis Polk team are based in the Northern California and New York offices.